Neural circuit and synaptic dysfunctions in ALS-FTD pathology
Action selection is a capital feature of cognition that guides behavior in processes that range
from motor patterns to executive functions. Here, the ongoing actions need to be monitored …
from motor patterns to executive functions. Here, the ongoing actions need to be monitored …
Recent advances in photochemistry for positron emission tomography imaging
JJ Zhang, L Lou, R Lv, J Chen, Y Li, G Wu, L Cai… - Chinese Chemical …, 2023 - Elsevier
As a powerful noninvasive imaging technology, positron emission tomography (PET) has
been playing an important role in disease theranostics and drug discovery. The successful …
been playing an important role in disease theranostics and drug discovery. The successful …
Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration
There is extensive synaptic loss from frontotemporal lobar degeneration, in preclinical
models and human in vivo and post mortem studies. Understanding the consequences of …
models and human in vivo and post mortem studies. Understanding the consequences of …
Longitudinal Synaptic Loss in Primary Tauopathies: An In Vivo [11C]UCB‐J Positron Emission Tomography Study
N Holland, PS Jones, G Savulich… - Movement …, 2023 - Wiley Online Library
Background Synaptic loss is characteristic of many neurodegenerative diseases; it occurs
early and is strongly related to functional deficits. Objective In this longitudinal observational …
early and is strongly related to functional deficits. Objective In this longitudinal observational …
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's …
S Das, MPE van Engelen, J Goossens… - Alzheimer's Research & …, 2024 - Springer
Background Lack of early molecular biomarkers in sporadic behavioral variants of
frontotemporal dementia (bvFTD) and its clinical overlap with primary psychiatric disorders …
frontotemporal dementia (bvFTD) and its clinical overlap with primary psychiatric disorders …
[HTML][HTML] In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review
M Visser, JT O'Brien, E Mak - Ageing Research Reviews, 2024 - Elsevier
Positron emission tomography (PET) with radiotracers that bind to synaptic vesicle
glycoprotein 2 A (SV2A) enables quantification of synaptic density in the living human brain …
glycoprotein 2 A (SV2A) enables quantification of synaptic density in the living human brain …
Bringing synapses into focus: Recent advances in synaptic imaging and mass-spectrometry for studying synaptopathy
N Hindley, A Sanchez Avila… - Frontiers in Synaptic …, 2023 - frontiersin.org
Synapses are integral for healthy brain function and are becoming increasingly recognized
as key structures in the early stages of brain disease. Understanding the pathological …
as key structures in the early stages of brain disease. Understanding the pathological …
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome
N Holland, G Savulich, PS Jones… - Movement …, 2024 - Wiley Online Library
Abstract Background/Objective The corticobasal syndrome (CBS) is a complex asymmetric
movement disorder, with cognitive impairment. Although commonly associated with the …
movement disorder, with cognitive impairment. Although commonly associated with the …
SV2A PET imaging in human neurodegenerative diseases
MS Bavarsad, LT Grinberg - Frontiers in Aging Neuroscience, 2024 - frontiersin.org
This manuscript presents a thorough review of synaptic vesicle glycoprotein 2A (SV2A) as a
biomarker for synaptic integrity using Positron Emission Tomography (PET) in …
biomarker for synaptic integrity using Positron Emission Tomography (PET) in …
In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction …
G Vanderlinden, C Carron, R Vandenberghe… - BMC Medical …, 2024 - Springer
Abstract Background 18F-FDG brain PET is clinically used for differential diagnosis in
cognitive dysfunction of unclear etiology and for exclusion of a neurodegenerative cause in …
cognitive dysfunction of unclear etiology and for exclusion of a neurodegenerative cause in …